← Back to headlines
Lilly's Zepbound-Containing Regimen Succeeds in Psoriasis Trial
Lilly announced that a regimen including its drug Zepbound demonstrated success in a clinical trial for treating psoriasis.
18 Feb, 12:26 — 18 Feb, 12:28
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual53d ago
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage study.
Read full article →seeking-alphaMixed53d ago
Lilly says Zepbound-containing regimen succeeded in a trial for psoriasis
Read full article →Coverage Timeline
First report: seeking-alpha · 18 Feb, 12:26|Full coverage: 2 · 2m|Window: 2m
Left-leaningCenterRight-leaning
Related Stories
Pathologist Shares Four Simple Rules for Weight Loss
30m ago
British Actress Nikki Sanderson Reveals Abuse Over Pregnancy in Her Forties
34m ago
Son of Blind College Football Player Completes Treatment for Rare Eye Cancer
39m ago
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
39m ago